Fig. 1
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Flow chart of the research methodology and design
Fig. 1 | Cancer Cell International
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Flow chart of the research methodology and design